Pharmacogenomics in Lebanon: current status, challenges and opportunities

Area of Science:

• Pharmacogenomics
• Genetics
• Clinical Medicine

Background:

• Lebanon's population exhibits significant genetic diversity, making pharmacogenomics (PGx) highly relevant.
• The country's established medical and educational infrastructure positions it to advance PGx research and application.
• A comprehensive review of existing PGx research and practice in Lebanon is needed.

Purpose of the Study:

• To evaluate the current landscape of pharmacogenomics (PGx) research in Lebanon.
• To describe the present status of PGx clinical practice, identifying local and regional challenges.
• To highlight opportunities and actionable steps for advancing PGx research, education, and implementation.

Main Methods:

• Literature review and evaluation of existing pharmacogenomics (PGx) research in Lebanon.
• Assessment of the current state of PGx practice, including challenges and opportunities.
• Case study analysis of PGx at the American University of Beirut Faculty of Medicine and Medical Center.

Main Results:

• The study reviews available PGx research and evaluates the current practice in Lebanon.
• It identifies challenges and opportunities for PGx implementation and education.
• The American University of Beirut serves as a model for developing comprehensive PGx programs.

Conclusions:

• Lebanon has significant potential to contribute to pharmacogenomics (PGx) research and clinical application.
• Addressing challenges and leveraging opportunities can advance PGx education and practice regionally.
• Developing integrated PGx programs is crucial for personalized medicine in Lebanon and the region.